Response to comments on "Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India".
作者信息
Ganesan Govindaraj, Ponniah Sasipriya, Sundaram Vivek, Marimuthu Praveen Kumar, Pitchaikannu Venkatraman, Chandrasekaran Manigandan, Thangarasu Janakiraman, Kannupaiyan Gunasekaran, Ramamoorthy Prabhu, Thangaraj Brindha, Vaishnavi Raguram Shree
机构信息
Harshamitra Super-Specialty Cancer Centre and Research Institute, India.
Sundaram Hospital, Trichy, India.
出版信息
Radiother Oncol. 2022 Feb;167:325. doi: 10.1016/j.radonc.2021.12.001. Epub 2021 Dec 8.
Abstract
摘要
相似文献
1
Response to comments on "Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India".对关于“全肺照射作为COVID-19的一种新治疗方法：印度一项正在进行的2期试验的中期结果”评论的回应
Radiother Oncol. 2022 Feb;167:325. doi: 10.1016/j.radonc.2021.12.001. Epub 2021 Dec 8.
2
Comments on "Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India".对《全肺照射作为COVID-19的一种新疗法：印度一项正在进行的2期试验的中期结果》的评论
Radiother Oncol. 2022 Feb;167:323-324. doi: 10.1016/j.radonc.2021.12.002. Epub 2021 Dec 8.
3
Response to "Comments on whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)".对《关于全肺照射作为COVID-19的一种新治疗方法：前瞻性随机试验（WINCOVID试验）的最终结果》的回应
Radiother Oncol. 2022 May;170:246. doi: 10.1016/j.radonc.2022.02.037. Epub 2022 Mar 10.
4
Comments on "Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)".对《全肺照射作为COVID-19的一种新治疗方法：前瞻性随机试验（WINCOVID试验）的最终结果》的评论
Radiother Oncol. 2022 May;170:244-245. doi: 10.1016/j.radonc.2022.02.035. Epub 2022 Mar 5.
5
Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study.印度基于灭活病毒的 SARS-CoV-2 疫苗 BBV152 的有效性：一项病例对照研究。
Lancet Infect Dis. 2022 Mar;22(3):349-356. doi: 10.1016/S1473-3099(21)00674-5. Epub 2021 Nov 23.
6
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.新型冠状病毒灭活疫苗在安全性和免疫原性方面的效果：两项随机临床试验的中期分析。
JAMA. 2020 Sep 8;324(10):951-960. doi: 10.1001/jama.2020.15543.
7
Interim estimates in null models of COVID-19 vaccine effectiveness.新冠肺炎疫苗有效性零模型的中期估计。
Int J Infect Dis. 2021 May;106:169-170. doi: 10.1016/j.ijid.2021.03.050. Epub 2021 Mar 18.
8
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.阿托伐他汀和阿司匹林作为 SARS-CoV-2 感染患者的辅助治疗：一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Oct 30;21(1):902. doi: 10.1186/s13063-020-04840-y.
9
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.一种灭活全病毒 SARS-CoV-2 疫苗（克尔来福）的有效性和安全性：在土耳其进行的一项双盲、随机、安慰剂对照、3 期临床试验的中期结果。
Lancet. 2021 Jul 17;398(10296):213-222. doi: 10.1016/S0140-6736(21)01429-X. Epub 2021 Jul 8.
10
Response to comments on: A pilot study on the perspectives of pediatric ophthalmologists and their patients towards online consultation during COVID-19 lockdown in India.对关于《印度新冠疫情封锁期间儿科眼科医生及其患者对在线咨询的看法的初步研究》评论的回应
Indian J Ophthalmol. 2021 Jan;69(1):164. doi: 10.4103/ijo.IJO_3553_20.
本文引用的文献
1
Comments on "Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India".对《全肺照射作为COVID-19的一种新疗法：印度一项正在进行的2期试验的中期结果》的评论
Radiother Oncol. 2022 Feb;167:323-324. doi: 10.1016/j.radonc.2021.12.002. Epub 2021 Dec 8.
2
Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India.全肺照射作为新型冠状病毒肺炎的一种新治疗方法：印度一项正在进行的2期试验的中期结果
Radiother Oncol. 2021 Oct;163:83-90. doi: 10.1016/j.radonc.2021.08.001. Epub 2021 Aug 12.
Zotero 插件